BRCA1 and familial pancreatic carcinoma: It has been shown that advanced pancreatic cancer with biallelic loss of BRCA1 and BRCA2 had a higher median tumor mutation burden than wild type tumors with the consequent possible higher sensitivity to ICIs [89].